ES2106076T3 - Composiciones y procedimientos para el tratamiento del acne vulgaris y el retraso del envejecimiento. - Google Patents

Composiciones y procedimientos para el tratamiento del acne vulgaris y el retraso del envejecimiento.

Info

Publication number
ES2106076T3
ES2106076T3 ES91906989T ES91906989T ES2106076T3 ES 2106076 T3 ES2106076 T3 ES 2106076T3 ES 91906989 T ES91906989 T ES 91906989T ES 91906989 T ES91906989 T ES 91906989T ES 2106076 T3 ES2106076 T3 ES 2106076T3
Authority
ES
Spain
Prior art keywords
acne vulgaris
treatment
aging
procedures
delay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91906989T
Other languages
English (en)
Inventor
Lit-Hung Leung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2106076T3 publication Critical patent/ES2106076T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN TRATAMIENTO COSMETICO PARA COMBATIR EL ACNE VULGARIS Y ALIVIAR LOS EFECTOS DEL ENVEJECIMIENTO DE LA PIEL COMPRENDE LA ADMINISTRACION DIARIA, EN DOSIS DIVIDIDAS, DE 2 A 20 GR. DE ACIDO PANTOTENICO O SU DERIVADO QUE PRODUCE ACIDO PANTOTENICO EN EL CUERPO, DE 0,5 A 3 GR. DE ACIDO NICOTINICO O SU DERIVADO QUE GENERA DINUCLEOTIDO DE ADENINA DE NICOTINAMIDA (DAN) O FOSFATO DE DINUCLEOTIDO DE ADENINA DE NICOTINAMIDA (FDAN) Y DE 5 A 50 GR. DE BIOTINA.
ES91906989T 1990-03-27 1991-03-27 Composiciones y procedimientos para el tratamiento del acne vulgaris y el retraso del envejecimiento. Expired - Lifetime ES2106076T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909006785A GB9006785D0 (en) 1990-03-27 1990-03-27 Composition and methods for treatment of acne vulgaris and retardation of ageing

Publications (1)

Publication Number Publication Date
ES2106076T3 true ES2106076T3 (es) 1997-11-01

Family

ID=10673309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91906989T Expired - Lifetime ES2106076T3 (es) 1990-03-27 1991-03-27 Composiciones y procedimientos para el tratamiento del acne vulgaris y el retraso del envejecimiento.

Country Status (13)

Country Link
US (2) US5459153A (es)
EP (1) EP0527757B1 (es)
JP (1) JP3409127B2 (es)
AT (1) ATE154879T1 (es)
AU (1) AU654812B2 (es)
CA (1) CA2078670C (es)
DE (1) DE69126703T2 (es)
DK (1) DK0527757T3 (es)
ES (1) ES2106076T3 (es)
GB (1) GB9006785D0 (es)
GR (1) GR3024544T3 (es)
HK (1) HK1001185A1 (es)
WO (1) WO1991014431A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
US5616617A (en) * 1995-11-27 1997-04-01 Van Moerkerken; Arthur Face pimples prevention method and compositions
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
US5939082A (en) * 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US6238678B1 (en) 1995-11-06 2001-05-29 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
JPH11508281A (ja) * 1996-04-23 1999-07-21 ザ、プロクター、エンド、ギャンブル、カンパニー ビタミンｂ▲下３▼化合物による皮膚外観の調整方法
USH2013H1 (en) 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
US5968528A (en) * 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
WO1999047113A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions for regulating skin appearance
FR2780888B1 (fr) * 1998-07-09 2000-10-13 Benac Lotion nettoyante et traitante destinee au traitement des comedons
AU5686799A (en) * 1998-08-27 2000-03-21 Procter & Gamble Company, The Methods of reducing the irritation associated with vitamin b3 compositions
PT1143954E (pt) * 1998-12-01 2004-12-31 Univ Kentucky Res Found Utilizacao de derivados de acido nocotinico para o tratamento de danos no adn em celulas da pele
US6444647B1 (en) 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6979468B1 (en) 2002-12-06 2005-12-27 Sirius Laboratories Oral composition and method for the treatment of inflammatory cutaneous disorders
US20050048012A1 (en) * 2003-08-26 2005-03-03 Roland Jermann Use of biotin or a biotin derivative for skin lightening purposes and for the treatment of senile lentigines
JP5338030B2 (ja) * 2007-01-31 2013-11-13 大正製薬株式会社 アダパレン含有外用剤組成物
US20100068334A1 (en) * 2008-09-12 2010-03-18 Damon Randolph Race Medicinal Food and Beverage Compositions and Related Methods for Managing Acne in Humans

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4885157A (en) * 1987-02-13 1989-12-05 Fiaschetti Mary G Dermal cosmetic composition and applications therefor
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
US4857321A (en) * 1988-08-26 1989-08-15 Thomas William C Skin ointment

Also Published As

Publication number Publication date
AU7565891A (en) 1991-10-21
DE69126703D1 (de) 1997-08-07
DE69126703T2 (de) 1998-02-05
AU654812B2 (en) 1994-11-24
GB9006785D0 (en) 1990-05-23
US5519039A (en) 1996-05-21
US5459153A (en) 1995-10-17
HK1001185A1 (en) 1998-05-29
JPH05505819A (ja) 1993-08-26
CA2078670A1 (en) 1991-09-28
ATE154879T1 (de) 1997-07-15
DK0527757T3 (da) 1998-01-19
EP0527757A1 (en) 1993-02-24
WO1991014431A1 (en) 1991-10-03
JP3409127B2 (ja) 2003-05-26
CA2078670C (en) 2003-02-11
GR3024544T3 (en) 1997-12-31
EP0527757B1 (en) 1997-07-02

Similar Documents

Publication Publication Date Title
ES2106076T3 (es) Composiciones y procedimientos para el tratamiento del acne vulgaris y el retraso del envejecimiento.
AUPR177300A0 (en) Therapeutic methods
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
MX9704988A (es) Derivados de hidroxilamina utiles para mejorar la produccion del acompañante molecular y la preparacion de los mismos.
GB2341605A (en) Therapeutic systems
DE3586935D1 (de) Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen.
CY2462B1 (en) Cyclohexyl dihydrobenzofuranes.
WO1999012951A8 (en) Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
NO164904C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive griseolsyrederivater.
MX9306049A (es) Dinucleotido de nicotinamida-ademina y fosfato de dinucleotido de nicotinamida-adenina como farmacos para tratar la enfermedad de alzheimer.
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
GR3021003T3 (en) Antineoplastic effect potentiator and antineoplastic agent
MX2024001581A (es) Derivados de ribosa modificados con 1'-alquilo y metodos de uso.
EP0301474A3 (en) New cysteine derivatives having expectorant activity
IL72330A (en) 3-alkyl-7-pyridyl-1h-triazolo(3,4-a)pyrimidine-5-one derivatives,their preparation and pharmaceutical compositions containing them
AU2003301513A1 (en) Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 527757

Country of ref document: ES